Please use this identifier to cite or link to this item: http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/4483
Coronavirus and the Heart A Case Report on the Evolution of COVID-19 Associated with Cardiological Evolution
arthur rente
Delcio Uezato Junior
Karina Margareth Kunyoshi Uezato
Acceso Abierto
Atribución
https://doi.org/10.36660/abc.20200263
Cardiovascular Diseases
Coronavirus
Myocarditis/complications
Respiratory Insufficiency
Beginning on December 31, 2019, in China, the coronavirus (Sars-Cov-2) has been the target of studies in the most diverse medical fields, with cardiology as one of the major pillars of evolution. Chronic diseases such as hypertension, diabetes mellitus and coronary artery disease dramatically increase the negative outcome of infected patients. According to data from the American College of Cardiology (ACC), in this profile of the general population, hospitalization levels resulting from COVID-19 hit 50% Due to infectious abnormalities resulting from infection, chronic comorbidities that until then were stabilized maytend to decompensate due to changes in supply and demand, among other factors of physiological responses to septic conditions. It is known that, previously, other pandemics of viral etiology, such as SARS and MERS, involved acute myocarditis with a tragic outcome from the cardiological point of view, and COVID-19 may be a source of acute myocarditis. According to data from the Brazilian Society of Cardiology (SBC), in March 2020, cardiovascular impairment related to the novel coronavirus has the following outcomes: arrhythmias (16%), myocardial ischemia (10%), myocarditis (7.2%) and shock (1–2%).
Sociedade Brasileira de Cardiologia
2020
Preimpreso
https://preprints.scielo.org/index.php/scielo/preprint/view/430
Inglés
Epidemia COVID-19
Investigadores
VIRUS RESPIRATORIOS
Appears in Collections:Artículos científicos

Upload archives